The department accused Actelion of violating the Anti-Kickback Statute by illegally using a nonprofit foundation as a conduit to pay copays for thousands of Medicare beneficiaries using the drugmaker’s pulmonary arterial hypertension drugs.
Actelion made donations to the foundation from 2014-15, then turned around and used the donations to cover copays for the drugs, according to the Justice Department. As a result, Actelion induced patients to select its drugs, which would have otherwise been unaffordable to many beneficiaries, according to the department.
More articles on pharmacy:
Walmart, 3 pharma companies sued over impure drugs
Justice Department wants to drop Supreme Court whistle-blower case against Gilead
GAO finds flaws in FDA’s orphan drug program: 6 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
